Invitation to Conference Call Regarding Promore Pharma’s Interim Report for the Third Quarter 2022
[ad_1] STOCKHOLM, SE / ACCESSWIRE / November 24, 2022 / Promore Pharma (STO:PROMO)(FRA:8T0) STOCKHOLM, 24 November 2022 – Promore Pharma AB (publ) publishes its interim report for the third quarter…